Marijuana moved to Schedule III. What changed for Arizona patients?

On 22 April 2026 marijuana stopped being a Schedule I drug — for some of it. The change was narrower than the headlines, and for a patient in Arizona the day-to-day effect is close to nil. It is still worth understanding, because the parts that did change are the parts that move prices.

What actually moved

The Department of Justice’s final order moved two categories into Schedule III: marijuana contained in an FDA-approved drug product, and marijuana subject to a state license authorizing its manufacture, distribution or dispensing for medical purposes.

Everything else stayed in Schedule I: adult-use marijuana, bulk marijuana not yet in an approved product, and synthetic THC. The DEA opened a separate hearing on 29 June 2026 to consider whether the rest should follow. That is unresolved.

So Arizona now has a split: the flower a registered patient buys from a licensed dispensary sits in Schedule III, and the identical flower sold to an adult-use customer in the same shop sits in Schedule I. The card is what puts you on the right side of that line.

What it changes for you

Prices, eventually. The biggest practical effect is tax, but not yours — the dispensary’s. Section 280E of the tax code bars businesses trafficking in Schedule I and II substances from deducting ordinary business expenses, which has taxed cannabis retailers at effective rates no other retailer faces. Schedule III removes that for the medical side. Whether any of it reaches the shelf price is up to the operators, and it will not happen in a week.

Research. Schedule III substances are far easier to study. Expect better evidence over the next few years about what cannabis does and does not do for the conditions on Arizona’s qualifying list.

Stigma, slightly. Schedule I formally means no accepted medical use. For state-licensed medical marijuana, the federal government no longer says that.

What it does not change

Your firearm rights. §922(g)(3) applies to unlawful users of a controlled substance in any schedule. No federal prescription exists for marijuana, so a card holder is still a prohibited person. Nothing about April 2026 altered that — see guns, DUI and employment.

Your job, if it is federal. Federal employment and DOT-regulated testing rules did not change. Schedule III substances are still tested for and still disqualifying without a valid prescription.

Crossing state lines. Interstate transport of marijuana remains a federal offense. Do not fly with it, do not mail it, and do not carry it across the Nevada or California border because both ends are legal.

Anything about Arizona’s program. The $150 AZDHS fee, the 2.5-ounce limit, the two-year card, the 16% excise exemption, the qualifying conditions — all state law, all untouched.

Does this mean I can get it prescribed now?

No. Schedule III drugs are prescribable in principle, but a prescription requires an FDA-approved product, and dispensary cannabis is not one. What your physician signs in Arizona is a certification under state law, not a prescription, and that distinction is the reason most of the federal consequences above survive.

Will the rest follow?

Possibly. The June 2026 hearing is considering exactly that, and several parties have challenged the April order from both directions. If adult-use marijuana also moves, the medical-only advantages discussed here would narrow. Until then, in Arizona the card is the thing that puts your purchase in Schedule III.

The state rules did not move: $299 for two years.

$149 evaluation + $150 AZDHS fee · 16% excise still skipped · 2.5 oz every 14 days.

Start my evaluation →

References

  1. DOJ final order signed 23 April 2026, published in the Federal Register 28 April 2026; effective 22 April 2026
  2. 21 U.S.C. §812 — schedules of controlled substances
  3. 26 U.S.C. §280E — deduction and credit disallowance for Schedule I and II trafficking
  4. DEA administrative hearing on broader rescheduling, opened 29 June 2026

Federal scheduling is live litigation and an open administrative proceeding. This page describes the position as of October 2026.